What Helps Primary Care Recognize and Refer?
One health system spent heavily on electronic health record software to detect proteinuria, only to find that primary care physicians would not use a tool requiring 2 clicks. “We started doing grand rounds in internal medicine to teach people. And that was actually more effective than the millions of dollars we spent on software,” said a health-system nephrologist.
An electronic consult service at San Francisco General allows specialists to triage the early referrals that growing primary care screening for diabetes and hypertension is producing, said Harini Sarathy, MBBS, MHS, of the University of California, San Francisco (UCSF). There is also a display on the electronic record’s main screen of the kidney failure risk equation that has helped primary care think about when to refer and may have increased referrals to chronic kidney disease care, though she was unsure how it affects rare kidney diseases.
How Are Teams Taking Access Work Off Physicians?
At UCSF, a specialty pharmacy team handles prior authorizations, appeals, and copay assistance while an embedded clinic pharmacist helps patients navigate access. One health system hands off to a dedicated team once a treatment decision is made, covering drug acquisition, delivery, and patient education. Another relies on a glomerular disease pharmacist to order medications and a weekly case conference for hard-to-manage patients.
However, gaps remain, such as when drugs ship from outside limited-distribution pharmacies and clinics lose sight of laboratory monitoring and therapy gaps, participants said, and several clinics lack social workers. “I don’t know what system, but we need to have extra help where physicians are not responsible for constantly following up,” Sarathy said.
Grimm said about 40% of his pediatric patients travel from the Central Valley, and families often must weigh missed work against clinic visits. “They have to make a choice: do I take my kid in for a doctor’s visit, or do I go and make some money to keep a roof over our head?” he said. His network’s year-long navigator program assigns a staff member to accompany high-need families to every appointment.
How Pathways Can Keep Pace With Evidence
Written protocols age quickly as therapies change, requiring rapid reviews of updates to the organization’s treatment guidelines. One transplant program wrote step-by-step protocols for recurrent IgA nephropathy, FSGS, and C3 glomerulopathy, where previously nothing was protocolized. “We wrote our first IgA guideline about a year and a half ago. Since then, we have actually revised it 3 times now,” said a transplant nephrologist.
One participant suggested pairing local guidelines with scheduled reviews because national guidance can lag new approvals and noted that some payers allow only one FSGS treatment, limiting options. Another participant called a physician-to-physician warm handoff key when patients move from pediatric to adult care, the easiest where systems share an electronic record.
A Key Change to Improve Outcomes
Faculty did not name a single fix, but coordination was a common thread. Sarathy noted that she would like more help to get patients through screening and treatment processes. Similarly, another participant said they would like a social worker for the clinic.
“I think that the word I loved the most that was spoken by multiple people today is ‘optimism,’ that we finally have approved therapies for these rare glomerular diseases, that things are really changing,” Hsu concluded.